Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 24
278
Views
12
CrossRef citations to date
0
Altmetric
Short Communications

Antiestrogenic and antiproliferative potency of secoisolariciresinol diglucoside derivatives on MCF-7 breast cancer cells

ORCID Icon, , , ORCID Icon & ORCID Icon
Pages 6099-6105 | Received 21 Apr 2020, Accepted 04 Sep 2020, Published online: 07 Oct 2020

References

  • Arken N. 2019. Schizandrol A reverses multidrug resistance in resistant chronic myeloid leukemia cells K562/A02. Cell Mol Biol (Noisy-le-Grand)). 65(1):78–83.
  • Buckner AL, Buckner CA, Montaut S, Lafrenie RM. 2019. Treatment with flaxseed oil induces apoptosis in cultured malignant cells. Heliyon. 5(8):e02251.
  • Chen LH, Fang J, Li H, Demark-Wahnefried W, Lin X. 2007. Enterolactone induces apoptosis in human prostate carcinoma LNCaP cells via a mitochondrial-mediated, caspase-dependent pathway. Mol Cancer Ther. 6(9):2581–2590.
  • Daina A, Michielin O, Zoete V. 2019. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 47(W1):W357–w364. Jul 2Epub 2019/05/21.
  • Dell'Albani P, Di Marco B, Grasso S, Rocco C, Foti MC. 2017. Quercetin derivatives as potent inducers of selective cytotoxicity in glioma cells. Eur J Pharm Sci. 101:56–65.
  • Di Y, De Silva F, Krol ES, Alcorn J. 2018. Flaxseed lignans enhance the cytotoxicity of chemotherapeutic agents against breast cancer cell lines MDA-MB-231 and SKBR3. Nutr Cancer. 70(2):306–315.
  • Gigliarelli G, Zadra C, Cossignani L, Robles Zepeda RE, Rascón-Valenzuela LA, Velázquez-Contreras CA, Marcotullio MC. 2018. Two new lignans from the resin of Bursera microphylla A. gray and their cytotoxic activity. Nat Prod Res. 32(22):2646–2651.
  • Graminha AE, Honorato J, Dulcey LL, Godoy LR, Barbosa MF, Cominetti MR, Menezes AC, Batista AA. 2020. Evaluation of the biological potential of ruthenium(II) complexes with cinnamic acid. J Inorg Biochem. 206:111021.
  • Kitts DD, Yuan YV, Wijewickreme AN, Thompson LU. 1999. Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol Cell Biochem. 202(1–2):91–100.
  • Kwak JH, Kang MW, Roh JH, Choi SU, Zee OP. 2009. Cytotoxic phenolic compounds from Chionanthus retusus. Arch Pharm Res. 32(12):1681–1687.
  • Laiolo J, Tomašič T, Vera DMA, González ML, Lanza PA, Gancedo SN, Hodnik Ž, Peterlin Mašič L, Kikelj D, Carpinella MC. 2018. Analogues of the lignan pinoresinol as novel lead compounds for P-glycoprotein (P-gp) Inhibitors. ACS Med Chem Lett. 9(12):1186–1192.
  • Li H, Krstin S, Wink M. 2018. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin. Phytomedicine. 50:213–222.
  • Morsy MA, El-Sheikh AAK, Ibrahim ARN, Khedr MA, Al-Taher AY. 2018. In silico comparisons between natural inhibitors of ABCB1/P-glycoprotein to overcome doxorubicin-resistance in the NCI/ADR-RES cell line. Eur J Pharm Sci. 112:87–94.
  • Morsy MA, El-Sheikh AAK, Ibrahim ARN, Venugopala KN, Kandeel M. 2020. In silico and in vitro identification of secoisolariciresinol as a re-sensitizer of P-glycoprotein-dependent doxorubicin-resistance NCI/ADR-RES cancer cells. PeerJ. 8:e9163.
  • Mueller SO, Simon S, Chae K, Metzler M, Korach KS. 2004. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci. 80(1):14–25.
  • Razavi SM, Zahri S, Zarrini G, Nazemiyeh H, Mohammadi S. 2009. Biological activity of quercetin-3-O-glucoside, a known plant flavonoid. Bioorg Khim. 35(3):414–416.
  • Salehi F, Jamali T, Kavoosi G, Ardestani SK, Vahdati SN. 2020. Stabilization of Zataria essential oil with pectin-based nanoemulsion for enhanced cytotoxicity in monolayer and spheroid drug-resistant breast cancer cell cultures and deciphering its binding mode with gDNA. Int J Biol Macromol. 164:3645–3655.
  • Shim GJ, Wang L, Andersson S, Nagy N, Kis LL, Zhang Q, Mäkelä S, Warner M, Gustafsson JA. 2003. Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis. Proc Natl Acad Sci USA. 100(11):6694–6699.
  • Stasevich OV, Mikhalenok SG, Kurchenko VP. 2009. Isolation of secoisolariciresinol diglucoside from lignan-containing extract of Linum usitatissimum seeds. Chem Nat Compd. 45(1):21–23.
  • Stasevich OV, Shman TV, Mikhalenok SG, Kurchenko VP. 2010. Dna-protector and cytotoxic activity of secoisolariciresinol diglucoside derivatives. Chem Nat Compd. 46(5):704–709.
  • Teodor ED, Moroeanu V, Radu GL. 2020. Lignans from medicinal plants and their anticancer effect. Mini Rev Med Chem. 20(12):1083–1090.
  • Waleka E, Mackiewicz M, Romanski J, Dybko A, Stojek Z, Karbarz M. 2020. Degradable nanohydrogel with high doxorubicin loadings exhibiting controlled drug release and decreased toxicity against healthy cells. Int J Pharm. 579:119188.
  • Zálešák F, Bon DJD, Pospíšil J. 2019. Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances. Pharmacol Res. 146:104284.
  • Zhu PL, Lam DF, Li JK, Fu XQ, Yin CL, Chou JY, Wang YP, Liu YX, Chen YJ, Wu JY, et al. 2020b. Gomisin N exerts anti-liver cancer effects and regulates PI3K-Akt and mTOR-ULK1 pathways in vitro. Biol Pharm Bull. 43(8):1267–1271.
  • Zhu L, Shen XB, Yuan PC, Shao TL, Wang GD, Liu XP. 2020a. Arctigenin inhibits proliferation of ER-positive breast cancer cells through cell cycle arrest mediated by GSK3-dependent cyclin D1 degradation. Life Sci. 256:117983.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.